Related references
Note: Only part of the references are listed.A randomized, placebo-controlled, double-blind phase IIb trial evaluating the safety and efficacy of tirasemtiv in patients with amyotrophic lateral sclerosis
Jeremy M. Shefner et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2016)
Being PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?
Neta Zach et al.
NEUROTHERAPEUTICS (2015)
Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression
Robert Kueffner et al.
NATURE BIOTECHNOLOGY (2015)
Randomized phase 2 trial of NP001, a novel immune regulator
Robert G. Miller et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial
Merit E. Cudkowicz et al.
LANCET NEUROLOGY (2014)
The PRO-ACT database Design, initial analyses, and predictive features
Nazem Atassi et al.
NEUROLOGY (2014)
Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial
Merit E. Cudkowicz et al.
LANCET NEUROLOGY (2013)
Gradient boosting machines, a tutorial
Alexey Natekin et al.
FRONTIERS IN NEUROROBOTICS (2013)
The Split-Apply-Combine Strategy for Data Analysis
Hadley Wickham
JOURNAL OF STATISTICAL SOFTWARE (2011)
Clinical research methodology I: Introduction to randomized trials
Lillian S. Kao et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2008)
Fisher, Bradford Hill, and randomization
P Armitage
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2003)
Greedy function approximation: A gradient boosting machine
JH Friedman
ANNALS OF STATISTICS (2001)
Share Paper
